Romiplostim N01 Clinical Trials
5 recruitingDrug
Phase 22Phase 11Not Applicable1Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University88 enrolled1 locationNCT06759636
Recruiting
Phase 1
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Acute Myeloid LeukemiaHSCTMDS (Myelodysplastic Syndrome)+1 more
First Affiliated Hospital of Zhejiang University130 enrolled1 locationNCT07321626
Recruiting
Not Applicable
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT07206823
Recruiting
Phase 2
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT07063225
Recruiting
Phase 2
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital34 enrolled1 locationNCT06693791